IMN || News

Efficacy, not tolerability, of bowel prep is primary

Posted on: 09/10/2014 - 18:38

The efficacy, not the tolerability, of bowel cleansing is the primary concern in patients undergoing colonoscopy, because of the substantial adverse consequences of inadequate bowel preparation,...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: New drug shows efficacy in metastatic CRC

Posted on: 09/10/2014 - 16:13

MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...

Field of Interest: Oncology

Type: News Item

VIDEO: New drug shows efficacy in metastatic CRC

Posted on: 09/10/2014 - 16:13

MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...

Field of Interest: Gastroentero...

Type: News Item

CLEOPATRA sets new standard treatment paradigm for metastatic breast cancer

Posted on: 08/10/2014 - 14:15

MADRID – First-line dual targeted therapy with pertuzumab and trastuzumab plus chemotherapy gives women with HER2-positive metastatic breast cancer an additional 15.7 months of life, according to the...

Field of Interest: Oncology

Type: News Item

CLEOPATRA sets new standard treatment paradigm for metastatic breast cancer

Posted on: 08/10/2014 - 14:15

Field of Interest: Pulmonology

Type: News Item

Rolapitant curbs chemo-induced nausea and vomiting

Posted on: 07/10/2014 - 17:01

MADRID – The investigational neurokinin-1 receptor antagonist rolapitant met all of its endpoints in the prevention of chemotherapy-induced nausea and vomiting in a phase III trial. Among 532...

Field of Interest: Oncology

Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Oncology

Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

Field of Interest: Gastroentero...

Type: News Item

Biomarker predicts bone loss in premenopausal breast cancer patients

Posted on: 03/10/2014 - 19:17

CHICAGO – A premenopausal breast cancer patient’s follicle-stimulating hormone level upon completion of chemotherapy predicts her risk of bone loss during the ensuing 12 months, Dr. Laila S....

Field of Interest: Pulmonology

Type: News Item

Biomarker predicts bone loss in premenopausal breast cancer patients

Posted on: 03/10/2014 - 19:17

CHICAGO – A premenopausal breast cancer patient’s follicle-stimulating hormone level upon completion of chemotherapy predicts her risk of bone loss during the ensuing 12 months, Dr. Laila S....

Field of Interest: Oncology

Type: News Item

« first
‹ previous
…
50
51
52
53
54
55
56
57
58
…
next ›
last »

Newsletters

Stay informed on our latest news!

Latest Newsletters

randomness

You are here

Newsletters

Latest Newsletters